Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Sierra Purcell

Physician Assistant Chicago, IL Physician Assistant

NPI 1699412825 CMS profile 11425561

1 E Superior St Ste 306, Chicago, IL 60611

Open in the dashboard

General payments

$7,952

378 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sierra Purcell of Chicago, IL is reported in the CMS Open Payments database as having received $7,952 across 378 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,386 107
2024 General $3,448 175
2023 General $1,783 86
2022 General $335 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sierra Purcell
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Sierra Purcell were reported at $2,386. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Sierra Purcell Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $335 $155 $48–$522 $149
2023 $1,783 $167 $52–$557 $160
2024 $3,448 $178 $55–$600 $164
2025 $2,386 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. AbbVie, Inc. $1,800 87 payments
  2. Otsuka America Pharmaceutical, Inc. $1,333 43 payments
  3. ITI, Inc. $993 43 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $481 29 payments
  5. Axsome Therapeutics, Inc. $450 18 payments
  6. Lundbeck LLC $423 40 payments
  7. Janssen Pharmaceuticals, Inc $408 14 payments
  8. Neos Therapeutics, LP $337 22 payments
  9. Ironshore Pharmaceuticals Inc. $322 15 payments
  10. Supernus Pharmaceuticals, Inc. $275 17 payments
  11. Other $1,129 50 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $7,952 378 payments
Products named General payments · program years 2022–2025
  1. VRAYLAR Neuroscience $1,444 59 payments
  2. REXULTI Psychiatry $1,333 43 payments
  3. CAPLYTA $832 36 payments
  4. TRINTELLIX $481 29 payments
  5. Auvelity $450 18 payments
  6. REXULTI Psychiatry $423 40 payments
  7. SPRAVATO $408 14 payments
  8. VRAYLAR Neuroscience $356 28 payments
  9. Adzenys XR-ODT $337 22 payments
  10. JORNAY PM $322 15 payments
  11. Other $2,031 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

378 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record